Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium

Read the paper here: Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium

Heller S, et al. Considerations for assessing the potential effects of antidiabetes drugs on cardiac ventricular repolarization: A report from the Cardiac Safety Research Consortium. Am Heart J. 2015; 170(1): 23-35

Comparison of Quality-of-Life Measures after Radial versus Femoral Artery Access for Cardiac Catheterization in Women: Results of the SAFE-PCI for Women Quality-of-Life Substudy

View Paper Here

Connie N. Hess, MD, MHSa; Mitchell W. Krucoff, MDa; Shubin Sheng, MSa; Kevin J. Anstrom, PhDa; W. Britt Barham, BAa; Ian C. Gilchrist, MDb; Robert A. Harrington, MDc; Alice K. Jacobs, MDd; Roxana Mehran, MDe; John C. Messenger, MDf; Daniel B. Mark, MDa; Sunil V. Rao, MDa; aDuke Clinical Research Institute, Durham, NC; bHeart & Vascular Institute, Pennsylvania State University, College of Medicine, Hershey, PA; cDepartment of Medicine, Stanford University, Stanford, CA; dDepartment of Medicine, Boston University School of Medicine, Boston, MA; eCardiovascular Research Foundation, Mount Sinai Medical Center, New York, NY; fDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO

Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium

Read the paper here: Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium

Sager, et al. Assessment of Drug-induced Increases in Blood Pressure during Drug Development: Report from the Cardiac Safety Research Consortium. Leaders: Am Heart J. 2013; 165(4): 477-488

The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development

Read the paper here: The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development

Nada, et al. The Evaluation and Management of Drug Effects on Cardiac Conduction (PR and QRS Intervals) in Clinical Development. Am Heart J. 2013; 165(4): 489-500